Senator Hyde-Smith supports common-sense, patient-centered health care reforms to help Mississippi families afford health insurance coverage without expanding the government’s role in providing health care.  As she has throughout her public career, the Senator has maintained a sharp focus on improving rural health care.

Senator Hyde-Smith appreciates the role of the state’s universities to support federal research on better prevention and treatment efforts on chronic diseases, like diabetes, that affect Mississippians disproportionally.


HYDE-SMITH OFFERS BILL TO STRENGTHEN NIH RESEARCH CAPABILITIES IN SMALLER STATES

HYDE-SMITH OFFERS BILL TO STRENGTHEN NIH RESEARCH CAPABILITIES IN SMALLER STATES

Bill Seeks to Ensure Future of NIH Institutional Development Award Program

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today introduced legislation to strengthen a National Institutes of Health (NIH) program that aims to build U.S. biomedical research capacity by distributing funding more broadly around the country.

Hyde-Smith introduced the IDeA Reauthorization Act of 2024 (S.4968) to amend the...

HYDE-SMITH, AN ORIGINAL COSPONSOR, VOTES FOR PASSAGE OF KIDS ONLINE SAFETY ACT

HYDE-SMITH, AN ORIGINAL COSPONSOR, VOTES FOR PASSAGE OF KIDS ONLINE SAFETY ACT

U.S. Senate Moves Forward on First Major Internet Safety Legislation Since 1998

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today voted for Senate passage of sweeping legislation intended to establish new standards for holding Big Tech accountable in order to protect children from online dangers.

Hyde-Smith is an original cosponsor of the Kids Online Safety Act (KOSA) which the Senate approved...

HYDE-SMITH HEARTENED BY SCATHING REPORT ON PHARMACY BENEFITS MANAGERS PRACTICES

HYDE-SMITH HEARTENED BY SCATHING REPORT ON PHARMACY BENEFITS MANAGERS PRACTICES

Miss. Senator Says FTC Investigation Shows Consumers, Small Pharmacies Being Hurt by PBM Practices

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) today asked the Federal Trade Commission (FTC) to complete its investigation into pharmacy benefits managers (PBMs) following the release of an interim report indicating consumers are paying higher prices because powerful prescription drug middlemen have a...